MedTrace Logo

MAGNetic QRS-Fragmentation in Patients With Myocardial InfarcTion and Moderately RedUceD Ejection Fraction

NCT01972126 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2025-07-03

No results posted yet for this study

Summary

The MAGNetic QRS-Fragmentation in Patients with Myocardial InfarcTion and Moderately RedUceD Ejection Fraction (MAGNITUDE) study will assess in MI survivors with moderately reduced left ventricular function, whether non-invasive MFI QRS Fragmentation alone or in combination with parameters derived from a Holter recording can be used to identify a group of patients at high risk for SCD/life threatening ventricular arrhythmia.

Conditions

  • Acute Myocardial Infarction

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Clinical Research Institute

    collaborator UNKNOWN

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • K.-H. Kuck, Prof.Dr.med. · Asklepios Klinik St. Georg, Hamburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01972126 on ClinicalTrials.gov